Drugmaker Staff Cuts: One Company Reports No Change in FDA Interactions

Reports indicate potential disruptions to FDA operations because of drugmaker staff reductions. However, one company states it has not observed any changes in its interactions with the agency. Drug manufacturers have issued reports concerning possible interruptions in FDA-related processes, citing staff layoffs as a contributing factor. Countering those reports, one unnamed company disclosed they have not detected any alterations in their dealings with the FDA, suggesting a potentially inconsistent impact of industry layoffs on the agency’s operations.

Newsflash | Powered by GeneOnline AI
Date: April 28, 2025

Author

Mark Chiang